GORI SAVELLINI, GIANNI
 Distribuzione geografica
Continente #
NA - Nord America 4.595
EU - Europa 3.646
AS - Asia 2.153
SA - Sud America 440
AF - Africa 165
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 11.010
Nazione #
US - Stati Uniti d'America 4.526
RU - Federazione Russa 967
SG - Singapore 672
CN - Cina 602
IE - Irlanda 597
IT - Italia 546
GB - Regno Unito 391
BR - Brasile 362
VN - Vietnam 321
SE - Svezia 235
FR - Francia 217
DE - Germania 209
HK - Hong Kong 193
UA - Ucraina 169
FI - Finlandia 146
KR - Corea 100
ZA - Sudafrica 86
IN - India 53
BD - Bangladesh 48
CA - Canada 33
NL - Olanda 33
PL - Polonia 33
IQ - Iraq 31
AR - Argentina 30
CI - Costa d'Avorio 25
ES - Italia 25
JP - Giappone 24
MX - Messico 24
AT - Austria 17
TR - Turchia 17
NG - Nigeria 16
CZ - Repubblica Ceca 13
PK - Pakistan 13
CO - Colombia 12
EC - Ecuador 12
ID - Indonesia 11
SA - Arabia Saudita 9
BE - Belgio 7
EU - Europa 7
MA - Marocco 7
DZ - Algeria 6
KE - Kenya 6
TN - Tunisia 6
CH - Svizzera 5
CL - Cile 5
EG - Egitto 5
IL - Israele 5
PY - Paraguay 5
UY - Uruguay 5
UZ - Uzbekistan 5
AL - Albania 4
AU - Australia 4
TH - Thailandia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HU - Ungheria 3
IR - Iran 3
KZ - Kazakistan 3
LT - Lituania 3
LU - Lussemburgo 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PH - Filippine 3
PT - Portogallo 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
IM - Isola di Man 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
EE - Estonia 1
GD - Grenada 1
GI - Gibilterra 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 11.006
Città #
Dublin 579
Dallas 493
Fairfield 396
Ashburn 391
Singapore 361
Chandler 303
Moscow 280
Southend 275
Santa Clara 262
Woodbridge 223
Hong Kong 182
Seattle 180
San Jose 179
Wilmington 170
Beijing 163
Siena 162
Cambridge 146
Houston 138
Jacksonville 130
Hefei 106
Princeton 105
Seoul 98
Ho Chi Minh City 94
Ann Arbor 90
Helsinki 88
Los Angeles 88
Milan 80
Johannesburg 73
New York 72
Council Bluffs 68
Hanoi 68
Munich 65
The Dalles 63
Lauterbourg 59
Menlo Park 40
Nanjing 38
Rome 38
São Paulo 38
Fremont 36
Buffalo 34
Florence 29
Warsaw 29
Abidjan 25
Da Nang 25
Boardman 24
San Diego 23
Orem 22
Frankfurt am Main 21
Redondo Beach 21
Chicago 20
Montreal 19
London 18
San Mateo 18
Tokyo 18
Atlanta 17
Abuja 16
Haiphong 16
Shanghai 16
Dong Ket 14
Nanchang 14
Norwalk 14
Turku 14
Bengaluru 13
Lancaster 13
Lappeenranta 13
Rio de Janeiro 13
Baghdad 11
Chennai 11
Columbus 11
Denver 11
Hebei 11
Shenyang 11
Tianjin 11
Vienna 11
Brooklyn 10
Düsseldorf 10
Málaga 10
Phoenix 10
Manchester 9
Nuremberg 9
Poplar 9
Portsmouth 9
San Francisco 8
Venezia 8
Belo Horizonte 7
Biên Hòa 7
Brussels 7
Guangzhou 7
Hải Dương 7
Kunming 7
Amsterdam 6
Barnet 6
City of London 6
Mexico City 6
New Delhi 6
North Bergen 6
Olomouc 6
Charlotte 5
Erbil 5
Goiânia 5
Totale 7.218
Nome #
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 379
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 351
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 280
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 274
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 258
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 250
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 243
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 226
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus 224
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 224
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 224
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 222
Identification of a neutralizing epitope on tosv gn glycoprotein 215
Diagnostic tools for Toscana virus infection 214
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 212
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 207
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 206
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 202
Development of a mouse model for the study of Toscana virus pathogenesis 190
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 190
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector 190
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 190
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 189
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 184
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 184
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 184
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 181
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 177
Seronegative Vaccinees May Not Benefit From Multiple Booster Doses of MMR Vaccine in Restoring Immunity 176
Comparative performance of a new sars-cov-2 rapid detection system 175
Neutralizing antibody response of vaccinees to SARS-CoV-2 variants 173
Infectious Toscana virus in seminal fluid of young man returning from Elba Island, Italy 172
Nucleotide variability of Toscana virus M segment in strains isolated from clinical cases 171
Ubiquitin and not only unfolded domains drives toscana virus non-structural NSs protein degradation 171
Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation 169
Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era 166
How long can SARS-CoV-2 persist in human corpses? 164
Deletion of 82–85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication 162
A novel replication deficient paramyxovirus elicits strong virus neutralising antibody and T cell responses in mice. 162
Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience 161
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion 158
Epidemiology of Toscana virus in South Tuscany over the years 2011-2019 158
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine 155
Dysregulation of intracellular redox homeostasis by the SARS-CoV-2 ORF6 protein 151
Toscana virus infects dendritic and endothelial cells opening the way for the central nervous system 146
Immunoglobulin M seropositivity for Toscana virus in a random population sample in Sicily 144
SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells 135
Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia 134
Development of a vaccine against hRSV and hPIV3 using a replication deficient Sendai virus vector. 131
CD40L gene assembled to Immune-Reconstituted Influenza Virosome (IRIV) enhances the immunological and protective activity of a CEA anti-cancer vaccine. 122
Degradation of RIG-I and inhibition of IFN-beta induction by Toscana Virus NSs protein. 118
Development of a vaccine against Toscana Virus. 117
Toscana virus epidemiology: from Italy to beyond. 115
SARS-CoV-2 n protein targets TRIM25-mediated RIG-I activation to suppress innate immunity 114
null 103
Truncation of the C-terminal region of Toscana Virus NSs protein is critical for interferon-β antagonism and protein stability 103
null 94
null 94
Seroprevalence and risk factors for Toscana and Sicilian Virus infection in a sample population of Sicily (Italy). 91
In vivo study of the PTH-rP DNA/IRIV vaccine for immune response into humanized transgenic mouse. 79
RIG-I-mediated antiviral signalling is inhibited by toscana virus NSs protein. 78
Toscana virus induces IFN-β production by activation of the cellular sensor RIG-I. 73
Prevalence of Toscana and Sicilian phlebovirus antibodies in classic Kaposi’s sarcoma cases and control subjects in Sicily 65
RECOGNITION OF TOSCANA VIRUS NSs REGIONS INVOLVED IN RIG-I DEGRADATION AND IFN-b INHIBITION 64
In vivo study of the PTH-rP DNA/IRIV vaccine for immune response into humanized transgenic mouse. 64
null 41
Molecular Epidemiology of Toscana Virus in Northern and Central Italy Using Metagenomic Next-Generation Sequencing 17
Metagenomic sequencing discloses the virome composition of mosquitoes and sandflies from Central-Southern Tuscany, Italy 8
Phenotypic characterization of two neuroinvasive Toscana virus strains clinically associated with self-limited and persistent infections in human neural cells and brain organoids 8
Totale 11.172
Categoria #
all - tutte 37.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202171 0 0 0 0 0 0 0 0 0 0 0 71
2021/2022613 34 49 22 30 23 18 32 51 69 55 68 162
2022/20231.036 59 107 135 122 111 224 16 93 100 22 34 13
2023/2024950 29 50 74 73 36 222 341 17 7 12 13 76
2024/20251.933 70 98 177 109 246 129 136 100 210 76 200 382
2025/20264.196 339 576 424 578 830 169 527 136 180 230 158 49
Totale 11.172